相关实验视频
Updated: Sep 11, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.7K
抗糖尿病药物处方的趋势和模式:来自希腊电子处方数据库的见解
Stefanos Karakolias1, George Mavridoglou2, Nikolaos Polyzos3
1Department of Nursing, Democritus University of Thrace, Alexandroupolis, Greece.
Primary care diabetes
|August 13, 2025
概括
在希腊,降血糖药的处方显示向新型药类的转变,尽管胰岛素仍然是一个显著的成本. 这一趋势影响了糖尿病患者的医疗保健政策和药物管理.
科学领域:
- 药物经济学 药物经济学
- 内分泌学 在内分泌学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 糖尿病是一种日益严重的全球健康问题.
- 了解抗糖尿病药物处方趋势对于有效的糖尿病管理至关重要.
- 现实世界的数据为当前的临床实践提供了洞察力.
研究的目的:
- 分析希腊的抗糖尿病药物处方模式和趋势.
- 检查不同类型的抗糖尿病药物的数量,成本和演变.
- 根据医疗专业识别处方的变化.
主要方法:
- 使用希腊国家电子处方数据库 (2015-2021) 进行的回顾性观察研究.
- 包括所有确诊为糖尿病的患者.
- 对药物细节,处方模式和相关成本的描述性统计分析.
主要成果:
- 降血糖药物 (不包括胰岛素) 占处方剂量的86.1%.
- 胰岛素占总处方成本的28.3%.
- 观察到DPP-4抑制剂和GLP-1类似剂的增加趋势,一些旧药物的使用量下降. 处方因专业而异,主要是内科和全科医院.
结论:
- 希腊抗糖尿病药物处方模式的显著变化表明,希腊正在向新的药物类别转变.
- 这些发现需要对医疗保健政策进行调整,以节省新药的成本和提高胰岛素的可负担性.
- 对于患者过渡和胰岛素接入的管理策略至关重要.
相关概念视频
Oral Hypoglycemic Agents: Glinides
261
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
261
Oral Hypoglycemic Agents: Biguanides and Glitazones
296
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
296
Diabetes: Management and Pharmacotherapy
374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374
Glucagon-like Receptor Agonists
418
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
418
Prescription, Nonprescription and Orphan Drugs
845
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
845
Insulin: Dosing Regimen and Adverse Effects
259
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
259

